CurrentEndo
Get Weekly

Topic · page 37 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,441–1,480 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Metab

    SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients

    Cohort study

  2. Diabetes Res Clin Pract

    Age and sex differences of cardiovascular and mortality risks in Korean type 2 diabetes and prediabetes: An 8 million Korean nationwide population-based cohort study

    Cohort study

  3. Nat Med

    DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial

    Randomized controlled trial

  4. Diabetes Obes Metab

    Efficacy and safety of CT ‐868, a novel, fully biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double‐blind, randomized placebo controlled phase 2 trial

    Randomized controlled trial

  5. J Clin Endocrinol Metab

    Association of Glucose Response Shape in OGTT With Markers of Pancreatic Health and Inflammation Across Diverse Ages

    Cross-sectional study

  6. Diabetes Res Clin Pract

    Systematic review and meta-analysis of the prevalence and clinical profile of lean type 2 diabetes mellitus in Africa

    Meta-analysis

  7. Ann Intern Med

    Treatment With Canagliflozin Versus Placebo in Children and Adolescents With Type 2 Diabetes : A Randomized Clinical Trial

    Randomized controlled trial

  8. Diabetologia

    What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers

    Research article

  9. Cardiovasc Diabetol

    Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies

    Meta-analysis

  10. Diabetes Obes Metab

    Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection

    Cohort study

  11. Diabetologia

    Clinical utility of self-reported sleep duration and insomnia symptoms in type 2 diabetes prediction

    Cohort study

  12. Diabetologia

    Non-autoimmune diabetes in young people from Assam, India: the PHENOEINDY-2 study

    Cross-sectional study

  13. Cardiovasc Diabetol

    Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study

    Cohort study

  14. J Clin Endocrinol Metab

    Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing

    Cross-sectional study

  15. JAMA Intern Med

    Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes: The DASH4D Randomized Clinical Trial

    Randomized controlled trial

  16. JAMA Intern Med

    Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial

    Randomized controlled trial

  17. J Clin Endocrinol Metab

    Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort

    Secondary analysis

  18. Eur J Endocrinol

    Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study

    Randomized controlled trial

  19. Pediatr Obes

    Cost‐Effectiveness Analysis of an Intensive Lifestyle Intervention Versus Usual Care for Latino Youth With Prediabetes

    Randomized controlled trial

  20. Nat Med

    Multimodal AI correlates of glucose spikes in people with normal glucose regulation, pre-diabetes and type 2 diabetes

    Cohort study

  21. Diabetes Obes Metab

    HbA1c reduction with tirzepatide in people with type 2 diabetes: The contribution of weight loss assessed by a mediation analysis

    Randomized controlled trial

  22. BMJ Open Diabetes Res Care

    Urinary incontinence in US adults aged ≥55 years with type 2 diabetes and indications for SGLT2is: NHANES 2013–2020

    Cross-sectional study

  23. Diabetes Res Clin Pract

    Triglyceride glucose-waist height ratio index is a promising and robust glucose and lipid metabolism indicator for predicting long-term type 2 diabetes: insights from a Japanese prospective cohort data from 12 years

    Cohort study

  24. Cardiovasc Diabetol

    Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

    Secondary analysis

  25. Diabetes Care

    Risk of Phimosis Associated With SGLT2i Versus GLP-1RA: A Danish Cohort Study

    Cohort study

  26. Osteoporos Int

    DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients

    Diagnostic or prognostic study

  27. Diabetes Obes Metab

    Effects of pioglitazone with and without exercise training on cardiorespiratory fitness and oxygen uptake kinetics in type 2 diabetes

    Research article

  28. Diabetes Obes Metab

    Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetes

    Cohort study

  29. Diabetes Care

    Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study

    Cohort study

  30. Diabetes Care

    Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis

    Secondary analysis

  31. J Diabetes Sci Technol

    Telemedicine Decreases No-Show Rates and Achieves Comparable Outcomes in Publicly Insured Patients With Type 2 Diabetes

    Cohort study

  32. Diabetes Obes Metab

    Decreases in circulating ANGPTL3 /8 concentrations following retatrutide treatment parallel reductions in serum lipids

    Secondary analysis

  33. Diabetes Obes Metab

    Evaluating biased agonism of glucagon‐like peptide‐1 ( GLP ‐1) receptors to improve cellular bioenergetics: A systematic review

    Meta-analysis

  34. Diabetes Obes Metab

    Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial

    Randomized controlled trial

  35. Diabetes Technol Ther

    Ease of Use of the Reusable DuraTouch Pen Injector in Individuals with Diabetes with and Without Previous Pen Injector Experience: A Handling Study

    Research article

  36. Diabet Med

    Illustrating stories of stigma from the perspective of people living with diabetes while experiencing homelessness: An arts‐based community participatory research project

    Research article

  37. Diabet Med

    The impact of socio‐economic deprivation on the long‐term survival of people with diabetes and acute myocardial infarction: A nationwide cohort study

    Cohort study

  38. Diabetes Metab

    Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study

    Cohort study

  39. Diabetologia

    Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes

    Cohort study

  40. Diabetes Res Clin Pract

    Lean diabetes is one end of the spectrum of type 2 diabetes and not a separate entity

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,441–1,480 of 4,758, newest first